CELA, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 49
NA - Nord America 15
AS - Asia 8
Totale 72
Nazione #
IT - Italia 16
US - Stati Uniti d'America 15
FR - Francia 13
IE - Irlanda 8
DE - Germania 6
JP - Giappone 3
FI - Finlandia 2
SE - Svezia 2
SY - Repubblica araba siriana 2
VN - Vietnam 2
CN - Cina 1
ES - Italia 1
NL - Olanda 1
Totale 72
Città #
Dublin 8
Frankfurt am Main 6
Chieti 5
Columbus 5
Treviso 5
Yokohama 3
Ashburn 2
Dong Ket 2
Lappeenranta 2
Paris 2
Stockholm 2
Los Angeles 1
Milan 1
Oxford 1
Pescara 1
Rome 1
San Vito Chietino 1
Shenyang 1
The Bronx 1
Toledo 1
Totale 51
Nome #
Nucleophosmin in its interaction with ligands, file e4233f18-20de-2860-e053-6605fe0a460a 34
KDEL Receptors: Pathophysiological Functions, Therapeutic Options, and Biotechnological Opportunities, file e4233f19-6d50-2860-e053-6605fe0a460a 12
Proteomic Investigation of the Role of Nucleostemin in Nucleophosmin-Mutated OCI-AML 3 Cell Line, file ddea53ec-4a0d-4414-af9d-e8576226dc53 9
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma, file 964f00b4-a892-436e-b396-946d6d41f49f 7
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma, file a289b249-cb14-4c5e-b641-511a38584754 5
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target, file b81e5c5f-a118-4da4-a6b3-237f50c2d07c 5
Totale 72
Categoria #
all - tutte 427
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 427


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 1 1 0 1 0 0 2
2021/20222 0 0 0 0 0 0 0 0 0 0 0 2
2022/202323 1 0 0 1 0 2 2 2 0 0 10 5
2023/202442 0 5 3 2 5 10 2 1 6 1 7 0
Totale 72